author-photo

Hiroshi Isobe

Hokkaido University

210

Papers

7423

Citations

Citation Trend

Filter By

Papers (140) Sort By

Journal Conference Others

Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902).

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (2)
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002).

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703).

2020 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

2020 Japanese Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival.

2020 Heliyon
Show All
- Source
- Cite
- Save
Citations (2)
Cerium oxide (CeO2-x) nanoparticles with high Ce3+ proportion synthesized by pulsed plasma in liquid

2020 Ceramics International
Show All
- Source
- Cite
- Save
Citations (3)
Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202)

2019 Japanese Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
1572PA prospective phase II trial of carboplatin (CBDCA) and nab-paclitaxel (nabPTX) for advanced non-small cell lung cancer (NSCLC) with interstitial lung disease (ILD)

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 4029: Analysis of DLL3 and ASCL1 in surgically resected small cell lung cancer (HOT1702)

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)